Short answer
Vericel Corp (VCEL) filed its Q2 2026 10-Q quarterly report on Jul 30, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $77M (up 22.5% year over year) with net income of $2M.
Q2 2026 key financials · XBRL
- Revenue
- $77M
- +22.5% YoY · +13.2% QoQ
- Net income
- $2M
- +498.9% YoY · +135.0% QoQ
- Operating margin
- 0.6%
- Gross margin
- 72.8%
- EPS (diluted)
- $0.04
- +500.0% YoY · +133.3% QoQ
Source: XBRL data from the Vericel Corp (VCEL) Q2 2026 10-Q on SEC EDGAR. USD.
Vericel Corp Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q2 revenue $77.5M, up 22.5% YoY from $63.2M, driven by MACI and Epicel
- Operating margin 0.6% vs (3.2)% YoY; net income $2.2M vs $0.6M loss
- Best performer MACI revenue $65.5M, up 22.5%; worst performer NexoBrid $1.5M, up 32.5%
- Cash, equivalents and restricted cash increased $25.3M in six months; operating cash flow $32.6M vs $14.8M
- $200.0M share-repurchase authorization; outlook includes U.K. MACI approval efforts and manufacturing, supply-chain and reimbursement headwinds
Risk Factors
- No material changes to 2025 Form 10-K risk factors as of July 30, 2026
- Carried-forward risk: undisclosed or currently immaterial risks could impair business or results of operations
- Carried-forward risk: identified factors could materially adversely affect results of operations or financial condition
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Vericel Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.